Table 1 Baseline characteristics of the study population
Intervention group (n = 81) | Control group (n = 79) | p value | |
|---|---|---|---|
Age (years)* | 69.9 (3.6) | 71.7 (4.2) | 0.004 |
Females (n, %) | 50 (61.7%) | 48 (60.8%) | 0.900 |
Marital status (n, %) | 0.169 | ||
Single | 2 (2.5%) | 8 (10.1%) | |
Married | 62 (76.5%) | 53 (67.1%) | |
Separated or divorced | 6 (7.4%) | 4 (5.1%) | |
Widower | 11 (13.6%) | 14 (17.7%) | |
Number of cohabitants (number) | 2.1 (1.1) | 2.0 (0.9) | 0.264 |
Educational level completed (n, %)* | 0.006 | ||
University studies | 24 (29.6%) | 7 (8.9%) | |
Middle or High school | 22 (27.2%) | 27 (34.2%) | |
Elementary school | 35 (43.2%) | 41 (51.9%) | |
None | 0 (0.0%) | 4 (5.0%) | |
Dietary habits stage of change (n, %) | 0.676 | ||
Precontemplation | 3 (3.7%) | 1 (1.3%) | |
Contemplation | 5 (6.2%) | 8 (10.0%) | |
Preparation | 3 (3.7%) | 1 (1.3%) | |
Action | 0 (0.0%) | 1 (1.3%) | |
Maintenance/termination | 70 (86.4%) | 68 (86.1%) | |
Physical activity stage of change (n, %) | 0.293 | ||
Precontemplation | 7 (8.6%) | 7 (8.9%) | |
Contemplation | 8 (9.9%) | 3 (3.8%) | |
Preparation | 6 (7.4%) | 5 (6.3%) | |
Action | 0 (0.0%) | 2 (2.5%) | |
Maintenance/termination | 60 (74.1%) | 62 (78.5%) | |
Diabetes (n, %) | 16 (19.8%) | 19 (24.1%) | 0.511 |
Dyslipidemia (n, %) | 43 (53.1%) | 39 (49.4%) | 0.638 |
Hypertension(n, %) | 34 (42.0%) | 45 (57.0%) | 0.058 |
Depression (n, %) | 9 (11.1%) | 15 (19.0%) | 0.162 |
Anxiety (n, %) | 11 (13.6%) | 12 (15.2%) | 0.822 |
Charlson Comorbidity Index | 2.9 (1.1) | 3.2 (1.0) | 0.073 |
Smokers (n, %) | 1 (1.2%) | 4 (5.1%) | 0.164 |
Obesity (n, %) | 20 (24.7%) | 27 (34.2%) | 0.170 |
Antiaggregants drugs (n, %) | 6 (7.4%) | 14 (17.7%) | 0.052 |
Anticoagulants drugs (n, %) | 4 (4.9%) | 3 (3.8%) | 0.737 |
Hypothyroidism treatment (n, %) | 12 (14.8%) | 6 (7.6%) | 0.148 |
Lipd-lowering drugs (n, %) | 32 (39.5%) | 36 (45.6%) | 0.438 |
Antihypertensive drugs (n, %) | 34 (42.0%) | 42 (53.2%) | 0.156 |
Antidiabetic drugs (n, %) | 14 (17.3%) | 15 (19.0%) | 0.780 |
Nonsteroidal anti-inflammatory drugs (n, %) | 9 (11.1%) | 8 (10.1%) | 0.884 |
Anxiety drugs (n, %) | 6 (7.4%) | 8 (10.1%) | 0.543 |
Depression drugs (n, %) | 8 (9.9%) | 11 (13.9%) | 0.481 |